Literature DB >> 8387906

Characterization and regulation of corticotropin-releasing factor receptors in the central nervous, endocrine and immune systems.

D E Grigoriadis1, J A Heroux, E B De Souza.   

Abstract

Corticotropin-releasing factor (CRF) plays a major role in coordinating the endocrine, autonomic, behavioural and immune responses to stress through actions in the brain and in the periphery. CRF receptors identified in brain, pituitary and spleen have comparable kinetic and pharmacological characteristics, guanine nucleotide sensitivity and adenylate cyclase-stimulating activity. Differences were observed in the molecular mass of the CRF receptor complex between brain (58,000 Da) and pituitary and spleen (75,000 Da), which appeared to be due to differential glycosylation of the receptor proteins. In autoradiographic studies, CRF receptors were localized in highest densities in anterior and intermediate lobes of the pituitary, olfactory bulb, cerebral cortex, amygdala, cerebellum and the macrophage-rich marginal zones and red pulp regions of the spleen. CRF can modulate the number of CRF receptors in both the brain and pituitary in a reciprocal manner. The demonstration of functional CRF receptors in brain, pituitary and spleen suggests the importance of this neuropeptide in integrating the responses of the CNS, endocrine and immune systems to physiological, psychological and immunological stimuli.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8387906     DOI: 10.1002/9780470514368.ch5

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  8 in total

1.  Type 7 adenylyl cyclase-mediated hypothalamic-pituitary-adrenal axis responsiveness: influence of ethanol and sex.

Authors:  Sergey P Pronko; Laura M Saba; Paula L Hoffman; Boris Tabakoff
Journal:  J Pharmacol Exp Ther       Date:  2010-04-02       Impact factor: 4.030

Review 2.  Human endometrium as a neuroendocrine tissue: expression, regulation and biological roles of endometrial corticotropin-releasing hormone (CRH) and opioid peptides.

Authors:  E Zoumakis; A N Margioris; A Makrigiannakis; C Stournaras; A Gravanis
Journal:  J Endocrinol Invest       Date:  1997-03       Impact factor: 4.256

3.  The developmental profile of the corticotropin releasing factor receptor (CRF2) in rat brain predicts distinct age-specific functions.

Authors:  M Eghbal-Ahmadi; C G Hatalski; T W Lovenberg; S Avishai-Eliner; D T Chalmers; T Z Baram
Journal:  Brain Res Dev Brain Res       Date:  1998-04-17

4.  The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist.

Authors:  T Z Baram; D T Chalmers; C Chen; Y Koutsoukos; E B De Souza
Journal:  Brain Res       Date:  1997-10-03       Impact factor: 3.252

5.  Block of T lymphocyte differentiation by activation of the cAMP-dependent signal transduction pathway.

Authors:  E Lalli; P Sassone-Corsi; R Ceredig
Journal:  EMBO J       Date:  1996-02-01       Impact factor: 11.598

6.  Differential regulation of the expression of corticotropin-releasing factor receptor type 2 (CRF2) in hypothalamus and amygdala of the immature rat by sensory input and food intake.

Authors:  M Eghbal-Ahmadi; S Avishai-Eliner; C G Hatalski; T Z Baram
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

7.  Peptide-induced infant status epilepticus causes neuronal death and synaptic reorganization.

Authors:  T Z Baram; C E Ribak
Journal:  Neuroreport       Date:  1995-01-26       Impact factor: 1.837

Review 8.  Physiological and neurochemical aspects of corticotropin-releasing factor actions in the brain: the role of the locus coeruleus.

Authors:  H Lehnert; C Schulz; K Dieterich
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.